Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,082 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies.
Hsu WF, Wang HW, Chen CK, Lai HC, Chuang PH, Tsai MH, Su WP, Chen HY, Chu CS, Chou JW, Chen SH, Tsai TY, Hsiao WD, Lin CC, Huang GT, Lin JT, Peng CY. Hsu WF, et al. Among authors: chen hy, chen sh, chen ck. Am J Cancer Res. 2021 Dec 15;11(12):6173-6187. eCollection 2021. Am J Cancer Res. 2021. PMID: 35018250 Free PMC article.
Combined Liver Stiffness and Α-fetoprotein Further beyond the Sustained Virologic Response Visit as Predictors of Long-Term Liver-Related Events in Patients with Chronic Hepatitis C.
Chen SH, Lai HC, Su WP, Kao JT, Chuang PH, Hsu WF, Wang HW, Hsieh TL, Chen HY, Peng CY. Chen SH, et al. Among authors: chen hy. Can J Gastroenterol Hepatol. 2022 Jul 4;2022:5201443. doi: 10.1155/2022/5201443. eCollection 2022. Can J Gastroenterol Hepatol. 2022. PMID: 35837486 Free PMC article.
Combined CRAFITY score and α-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving anti-programmed death-1 blockade-based immunotherapy.
Hsu WF, Lai HC, Chen CK, Wang HW, Chuang PH, Tsai MH, Chen SH, Chu CS, Su WP, Chou JW, Kao JT, Chen HY, Chuang SC, Tsai TY, Hsiao WD, Huang GT, Peng CY. Hsu WF, et al. Among authors: chen hy, chen sh, chen ck. Am J Cancer Res. 2023 Feb 15;13(2):654-668. eCollection 2023. Am J Cancer Res. 2023. PMID: 36895987 Free PMC article.
5,082 results